Sharemaestro Newsreel

Morgan Stanley, Johnson & Johnson And 3 Stocks To Watch Heading Into Wednesday

Morgan Stanley, Johnson & Johnson, Pentair PLC, ASML Holding NV, and Progressive Corp. are among the stocks to watch heading into Wednesday's trading. Morgan Stanley, Johnson & Johnson, and Progressive Corp. are set to release their quarterly earnings reports. Pentair PLC announced a CFO …

Should Gilead’s Revenue Beat but Softer EPS Outlook Require Action From Gilead Sciences (GILD) Investors?

Gilead Sciences reported a Q3 revenue beat of US$6.96 billion, exceeding analysts' expectations by 1.5%, but concurrently issued a softer full-year earnings-per-share outlook. This outcome suggests that while sales are strong, the company faces challenges in translating this growth into sustained profitability, raising questions …

Johnson & Johnson (JNJ) approaches earnings after 2.3% weekly setback

The healthcare heavyweight reports July 15, with longer-period gains and lighter turnover making the setup more balanced than the weekly drop alone suggests.

Johnson & Johnson (JNJ) brings a 13.0% four-week climb into July 15 earnings

The Healthcare heavyweight has momentum in weekly context, while lighter volume keeps the pre-results setup from looking fully confirmed.

AbbVie’s range-top push rests on June’s 87.5M-share breakout, not fresh July volume

ABBV closed within 0.2% of its 52-week high after a 14.9% four-week run, but the latest advance came on 0.9x volume and leaves valuation distance stretched.

Novo Nordisk A/S (NVO) extends 30.0% 12-week advance as activity picks up

The healthcare heavyweight is recovering on weekly data, but the setup still lacks clean trend confirmation.

AbbVie Inc (ABBV) director acquisition adds insider angle to a strong tape

The disclosure gives investors a governance marker as the drugmaker trades with heavier turnover and firm relative performance.

Eli Lilly’s 10% week puts it 0.6% from a yearly high while Fair Value stretch widens

LLY finished at $1,208 after a strong week on above-average participation, but the stock now sits 51.1% above Sharemaestro Fair Value as Healthcare breadth remains selective.

Novartis’s 18.3M-share rebound keeps its 63-week Trend Signal intact, but pressure is still negative

Novartis outpaced its drugmaker group for the week on heavy volume, yet the broader confirmation picture is mixed as Market Dynamics remains below zero.

Novo Nordisk A/S (NVO) draws heavier tape as 12-week rebound reaches 30.0%

The healthcare heavyweight is recovering in weekly context, but Relative Strength remains negative and the trend signal has not reactivated.

Merck’s 13% week outruns drugmaker breadth and lands within 0.1% of its yearly high

MRK closed at $128.70 after a high-range advance on 64.4M shares, with the weekly Trend Signal still active but Market Dynamics short of a fresh buy confirmation.

Johnson & Johnson’s 54.9M-share high tests the limit of an unconfirmed advance

JNJ jumped 11.5% to finish just 0.2% below its 52-week high, but negative activity pressure and a 52% Fair Value premium keep the weekly setup from being one-sided.

AbbVie Inc (ABBV) gets a 17.0% weekly reset on heavy turnover

The healthcare heavyweight’s latest weekly move sharpened a broader four-week advance, though the trend signal has not yet turned active.

Scilex Holding Company (SCLX) Dips 5.2% as Stock Tests Key Support Levels - Technical Analysis

Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?

Johnson & Johnson (JNJ) insider filing adds an executive acquisition

The update gives investors a fresh ownership datapoint as the drugmaker is viewed through weekly market data rather than live intraday action.

Novartis AG ADR (NVS) preferred-stock disposal record meets firmer weekly tape

The insider-activity item is historical, while current market data show the healthcare ADR rising across recent weekly horizons with some pressure still present.

Scilex Q1 2026 Earnings: Stock Surges 44% Despite Negative EPS as Pipeline Progress Drives Optimism

Sanofi-ADR (NASDAQ:SNY): A High-Yield Dividend Stock with Strong Fundamentals

Scilex Holding Company Warrants (SCLXW) Live Share Price, Invest From India

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

Strong Buy Rating on Sanofi (SNY) Following Positive Study Resul

SCLX Q1 2026 Earnings: Widening Losses Amid No Revenue, Stock Rebounds - Analyst Consensus Shift

Scilex Holding Company (“Scilex”) Announces a Payment Date

SANOFI-ADR (NASDAQ:SNY): A Quality Dividend Stock with a 5.31% Yield and Strong Fundamentals

Earnings call transcript: Grifols Q1 2026 results show mixed signals, revenue miss

All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy

Amarin's Q1 Loss Narrower Than Expected, Sales Increase Y/Y

AMARIN ($AMRN) Releases Q1 2026 Earnings | AMRN Stock News

Amarin says overseas sales and cost cuts kept cash flow positive

Earnings call transcript: Amarin Q1 2026 shows revenue growth amid restructuring

Datavault AI secures $120M from Scilex for edge network expansion

Datavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum Platform

Sanofi Tops Q1 Earnings Estimates as Dupixent & New Drugs Drive Growth

Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises

Sanofi (SNY) Q1 Earnings Exceed Expectations with Strong Sales G